Following the successful production of biosuccinic acid in 2012, operations have been moved from Reverdia to Roquette
Royal DSM and Roquette have decided to dissolve their joint venture company Reverdia. The company was created with the aim of producing biosuccinic acid, succeeding in 2012, with the product on the market under the name Biosuccunium.
Effective 1 April 2019, Reverdia will be dissolved and the partners will transfer the rights and obligations related to Reverdia’s Biosuccinium plant in Cassano, Italy to French-based Roquette.
DSM, the Dutch original developer of the Biosuccinium technology, will assume the role of exclusive licensor, in line with its business model in this field.
Under a non-exclusive licence from DSM, the plant-based ingredient supplier Roquette will then operate the plant and continue serving customers Biosuccinium. Customer service, order processing, marketing and sales will all be integrated into Roquette’s existing business.
Atul Thakrar, President of Bio-based Products and Services at DSM said: "The Reverdia joint venture has proven Biosuccinium technology to be the most sustainable and competitive bio-succinic acid on the market today. We have gone well beyond the start-up phase and the Biosuccinium brand will continue to grow under the leadership of our partner Roquette. This is an example of DSM doing what it does best — establishing market-leading technologies and commercialising them."
Found in foods such as broccoli, rhubarb, sugar beets, fresh meat extracts, various cheeses, and sauerkraut, biosuccinic acid is a platform molecule with applications in a range of large-volume markets.